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e recently demonstrated that
antibiotic administration has a
reproducible effect on the community
structure of the indigenous gastrointestinal microbiota of mice. In this addendum
we report on additional experimentation using the antibiotic vancomycin.
In accord with our previous findings,
vancomycin administration results in
consistent alteration of the microbiota of
the cecal contents and the cecal mucosa.
These alterations are largely reversed by
a three-week period of recovery without
antibiotics. In contrast to our previous
results using other antibiotics, the alterations in community structure associated
with vancomycin occured without a significant decrease in the overall bacterial
biomass. These results indicate that different antibiotics have specific effects on
the gut microbiota. This points the way
towards targeted, therapeutic alteration of the gut bacterial community as
a whole.
Introduction
The recent start of the Human
Microbiome Project by the NIH signals
a growing acceptance of the role of complex microbial communities in human
health and disease.1 It is important to
note however, that the idea that the indigenous microbiota can influence health is
not new. The concept of probiotics or
beneficial microbes, was put forth over
a century ago by Elie Metchnikoff not
long after the widespread acceptance of
Koch’s postulates for disease causation by
microbes.2
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More recently, the emergence of antibiotic associated diarrhea and colitis due to
Clostridium difficile raised general awareness that it was possible for the disease to
arise secondary to alterations in the indigenous microbiota.3 Shortly after Koch’s
postulates were fulfilled for C. difficile and
antibiotic associated colitis,4 it was demonstrated that the normal gut microbiota
could prevent this disease in an experimental animal model.5 Only recently
however have we developed the scientific
tools that allow us to profile the community structure of the indigenous microbiota and follow its dynamics.6
Antibiotic Administration Modifies
the Gut Microbiota
Culture-independent methods for the profiling of complex microbial communities,
such as construction and analysis of 16S
rRNA-encoding gene clone libraries, were
initially developed by investigators studying environmental consortia of bacteria.7,8
The efforts of the Human Microbiome
Project are the direct descendents of these
earlier works. We have used these techniques to begin exploration of the underlying role of the indigenous microbiota and
antibiotic associated diarrhea both related
to and independent of C. difficile infection. We recently reported that patients
with recurrent C. difficile infection possessed a microbiota that was characterized
by a markedly reduced overall diversity
compared to controls and patients with an
initial episode of disease.9 In an attempt
to understand how long-lasting changes
in the community structure of the
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indigenous gut microbiota could arise we
undertook a series of experiments involving antibiotic treatment of mice to follow
community dynamics under this ecologic
stress.
In an article published recently in
Infection and Immunity, we presented the
results of our study that temporally followed changes in the structure of the
indigenous gut microbiota after antibiotic
administration.10 In this study, two separate antibiotic regimens were employed to
perturb the gut microbiota. Treatment of
mice with a combination of amoxicillin,
metronidazole and bismuth resulted in
significant changes in the overall abundance and community composition of
the gut microbiota. However, following
withdrawal of this antibiotic combination,
there was a significant recovery of the gut
community towards baseline. Conversely,
while treatment with the broad-spectrum
antibiotic cefoperazone also resulted in
significant disturbance to the community,
withdrawal of this particular antibiotic
resulted in longer-lasting changes in community structure. In particular, animals
that were treated with cefoperazone possessed gut microbial communities that
were still depressed in terms of overall
diversity despite recovery of overall bacterial biomass six weeks after the withdrawal
of the antibiotic. Interestingly, introduction of a non-treated animal into the cage
housing cefoperazone-treated animals
after withdrawal of the antibiotic resulted
in normalization of the microbial community, presumably via corprophagy. This
latter observation has parallels in clinical
medicine in that transplantation of normal human feces has been used for the
treatment of recurrent C. difficile infection. A recent publication from another
group demonstrated that in a single
patient who underwent this treatment, the
reduced overall diversity of the gut bacteria community was reversed by treatment
with donor stool.11
We are grateful for the reception our
work has received from the scientific
community at large since publication.
Other investigators have had a number
of questions regarding our study and we
will address one of these more common
questions in this communication as well
as present some additional data we have
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generated. The most common question
we have received regards the rationale
for the selection of the two antibiotic
regimens that were reported. Our initial interest in the microbial ecology of
the gastrointestinal tract stems from an
interest we have in inflammatory bowel
disease (IBD). We utilize a murine
model of IBD in which gastrointestinal
inflammation is triggered in interleukin
10-deficient mice by challenge with the
bacterium Helicobacter hepaticus.12,13 We
are interested in determining what role
the indigenous gut microbiota has in the
modulation of IBD triggered by H. hepaticus. The two antibiotic regimens that we
chose were selected because of our interest
in this murine model of IBD. The combination of amoxicillin, metronidazole
and bismuth is available in a commercial
formulation with rodent chow and was
designed for control of Helicobacter infection in mouse colonies.14,15 Conversely, the
antibiotic cefoperazone is used in selective media designed to isolate H. hepaticus
from murine fecal pellets and tissue.13,16
Therefore, our experiments were designed
as control experiments to determine what
effect these two antibiotic regimens would
have on the baseline gut microbiota.
Effects of Vancomycin
Administration on the Indigenous
Gut Microbiota
We have extended our analysis of the
effect of antibiotics on the indigenous
gut microbiota by using additional regimens with distinct antimicrobial spectra.
Vancomycin is a glycopeptide antibiotic
with a spectrum of activity restricted
to Gram-positive organisms due to its
inhibitory activity against peptidoglycan
synthesis.17 Wild-type C57BL/6 mice were
treated with vancomycin at a concentration of 100 mg per liter in sterile water for
10 days. Two mice were sacrificed at the
end of this ten-day treatment with antibiotics while three mice were transferred
to untreated sterile water for a period of
three weeks prior to sacrifice. Cecal tissue
was collected and processed for microbial
ecology analysis as in our recent publication. In addition to the cecal tissue, which
contained the mucosa-associated microbiota, we also collected luminal contents
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for analysis. The comparison was made
to four untreated littermates. As opposed
to the pyrosequencing approach that was
utilized in our prior study, standard 16S
rRNA-encoding gene clone libraries were
constructed for analysis of community
structure as published previously.9 A total
of 1,576 clones were retrieved from the
samples, with a range of 78–95 clones
per sample. Although construction of
clone libraries does not sample as deeply
as pyrosequencing, it is a technique that
can reveal significant shifts in community
structure.
OTU-based analyses with the program
mothur revealed that vancomycin reduced
the richness of the mucosal and luminal communities (Fig. 1 and Table 1).
Furthermore, communities exposed to
vancomycin are different in structure
when compared to control communities
(Fig. 2). Examination of the classifications of the partial SSU gene sequences
revealed that the microbial community in
control animals was, as expected, dominated by Firmicutes and Bacteroidetes
(Fig. 3). Among the Firmicutes there was
a dominance of members from the family
Lachnospiraceae. At baseline, the community of mucosa-associated organisms
was similar to that found in the lumen.
Following administration of vancomycin as observed for the other antibiotic
regimens, there was a marked shift in the
membership and community structure.
Members of the Proteobacteria became
much more prominent in both the lumen
and mucosa (p < 0.05 as determined by
Metastats18). Members of the Tenericutes
became more prominent in the mucosa
(p < 0.05), but were not detected in the
luminal contents. In the mucosa, there
was an overall decrease in the proportion of the 16S rRNA-encoding gene
sequences that were retrieved from members of the Firmicutes (p < 0.05), but this
proportion remained similar in the lumen.
While the Firmicutes in the lumen and
mucosa of control animals were dominated by members of the Lachnospiraceae,
this distribution changed significantly
following vancomycin administration.
In the lumen and mucosa members of
the Lactobacillaceae increased (p < 0.05
and p < 0.01, respectively), while members of the Lachnospiraceae decreased
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Figure 1. Reduction of richness in gut microbiota following vancomycin administration. Partial 16S rRNA-encoding gene sequences were obtained
from the cecal mucosa (A) and cecal contents (B) from individual mice treated with 10 days of vancomycin (Vancomycin,V), animals that received 10
days of vancomycin followed by a three-week recovery period without antibiotic (Recovered, R) and animals that received no antibiotics (Control, C).
Rarefaction curves were generated using mothur20 and OTUs were defined at the 0.03 cutoff (97% similarity).
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Table 1. Changes in the ecologic diversity of the cecal microbiota in vancomycin treated mice

Cecal mucosa

Cecal contents
*

Observed richness

Chao1 richness estimator
(95% c.i.)

Shannon diversity index
(95% c.i.)

Control

107

151 (128–198)

3.90 (3.75–4.05)

Vancomycin

12

15 (12–35)

1.87 (1.74–1.99)*

Recovered

83

96 (88–117)

4.04 (3.92–4.15)

Control

117

168 (142–220)

4.26 (4.14–4.38)

Vancomycin

6

7 (6–20)

0.74 (0.59–0.88)*

Recovered

61

86 (70–129)

3.48 (3.34–3.62)

significantly different when compared to control and recovered groups, p < 0.01; unpaired t-test.

Figure 2. Vancomycin alters community structure and recovery results in a return to near-baseline structure. UPGMA clustering of communities from the cecal mucosa (A) and cecal contents
(B) from individual mice treated vancomycin (Vancomycin), vancomycin followed by a three-week
recovery period without antibiotic (Recovered) and animals that received no antibiotics (Control).
Dendrogram was generated using distances reflecting community structure dissimilarity
(1-similarity). Community structure similarity was calculated in mothur20 using the Yue and
Clayton (θ) index at OTU0.03.

(both p < 0.01). These results are completely consistent with the known antibiotic spectrum of vancomycin. As
Gram-negative organisms, members of
the Proteobacteria would not be expected
to be susceptible to vancomycin because of
their outer membrane, which impedes the
ability of the antibiotic to encounter its target, the peptidoglycan precursor UDP-Nacetlymuramylpentapeptide.17 Likewise,
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most members of the Tenericutes, including those detected in this study, are likely
not susceptible to vancomycin, in this
case due to the lack of a cell wall which
would be comprised of peptidoglycan.19
Although they are Gram-positive organisms, lactobacilli are often phenotypically
resistant to the action of vancomycin.
Similar to what was noted in our previous study of amoxicillin, metronidazole
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and bismuth treatment,10 following a
three-week period without antibiotics, the
community richness and structure of the
cecal microbiota in vancomycin-treated
animals returned to near baseline status
(Figs. 1–3). The Firmicutes were once
again the dominant phylum encountered
and amongst these the Lachnospiraceae
were the dominant family. Although the
Bacteroidetes did not recover in the lumen
to levels that could be detected, despite
returning to the mucosa, the difference
between the abundances of luminal populations in control and recovered groups was
not statistically significant (p = 0.43). This
is a situation where pyrosequencing of the
communities, as was done in the previous
study, may have resulted in a more complete understanding of recovery dynamics in this system. When overall diversity
between the three groups of animals was
compared using an OTU-based approach
(Table 1), it is clear that the vancomycin
treatment reduced overall diversity, but the
three week period of recovery without antibiotics resulted in an increase of diversity
that was similar to that of the gut microbiota in the untreated animals.
One significant difference between
treament with vancomycin compared
to the previous two antibiotic regimens,
is that although vancomycin treatment
resulted in large shifts in community composition there was not a major decrease in
bacterial biomass. As in the previous study,
we used a quantitative PCR assay targeting the 16S rRNA-encoding gene to determine relative changes in bacterial biomass.
We have previously noted that treatment
with the antibiotic combination of amoxicillin, metronidazole and bismuth reduced
overall bacterial load in the cecal mucosa
by approximately 2.5 orders of magnitude and cefoperazone treatment resulted
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Figure 3. Distribution of phylogentic groups shift following vancomycin administration. Classification of partial 16S rRNA-encoding gene sequences
obtained from the cecal contents and cecal mucosa from mice treated with vancomycin (vancomycin) and vancomycin followed by a three-week
recovery period without antibiotic (recovered). Comparisons were made to the communities detected in untreated mice (control). Sequences were
analyzed and classified to the level of phylum (outer ring) and family (inner pie chart) using the RDP Classifier. 21

in a three orders of magnitude decrease.
Conversely, vancomycin treatment did
not significantly change overall bacterial
load in the mucosa (fold change mucosa =
0.318 ± 0.267, p = 0.24; Kruskal-Wallis).

models of inflammatory bowel diseases.
It is our hope that the insight from these
studies will lead the way to novel methods
for treatment of IBD.

Conclusions

We thank Dr. Dion Antonopoulos for
his work on the original manuscript and
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for technical assistance. This work was
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DK070875-03S1 (Vincent B. Young).

In order to understand the role that the
indigenous microbiota can play in health
and disease within the gastrointestinal
tract, it is important to be able to understand the dynamics of this community.
Understanding how the community reacts
to a given ecologic stressor will give us
insight into how the microbiota assembles
and maintains community structure. Our
work with various antibiotic treatments
and the effect that they have on the gut
microbiota has demonstrated that while
these effects are reproducible for a given
treatment, the specific effects will vary.
Presumably, this could lead to different
changes in the function of the gut microbial community. Now that we have a better
understanding of the specific changes that
various antibiotic treatments have on the
gut microbes, we are currently conducting
experiments that determine if these alterations and community structure modify
the inflammatory response in murine
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